Literature DB >> 7908335

Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse.

C Salzman1.   

Abstract

Benzodiazepines are widely prescribed drugs. Most patients are prescribed benzodiazepines for short periods of time for anxiolytic or hypnotic purposes. However, some benzodiazepines are also used for extended periods at high doses to treat panic and agoraphobic disorders. When chronically prescribed benzodiazepines are discontinued, a predictable pattern of discontinuance symptoms may develop, indicating physiological dependence. Benzodiazepines also produce a variety of side effects including sedation, reduced coordination, and impaired cognition, which are primarily related to dose and duration of treatment. Benzodiazepines are commonly used by polysubstance abusers but their abuse as recreational drugs when taken alone is rare, and high-dose treatment for panic and agoraphobic symptoms does not lead to abuse. Prescribing guidelines are offered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7908335     DOI: 10.1016/0022-3956(93)90021-s

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  9 in total

1.  Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.

Authors:  Michael W Otto; R Kathryn McHugh; Naomi M Simon; Frank J Farach; John J Worthington; Mark H Pollack
Journal:  Behav Res Ther       Date:  2010-04-28

2.  Cognitive Behavioral Therapy Reduces Benzodiazepine Anxiolytics Use in Japanese Patients with Mood and Anxiety Disorders: A Retrospective Observational Study.

Authors:  Aiichiro Nakajima; Ayako Kanie; Masaya Ito; Naotsugu Hirabayashi; Fumi Imamura; Yoshitake Takebayashi; Masaru Horikoshi
Journal:  Neuropsychiatr Dis Treat       Date:  2020-09-18       Impact factor: 2.570

Review 3.  Addiction to benzodiazepines.

Authors:  C Salzman
Journal:  Psychiatr Q       Date:  1998

Review 4.  Generalised anxiety disorder: treatment options.

Authors:  John J Sramek; Victoria Zarotsky; Neal R Cutler
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  What treatments do patients with panic disorder and agoraphobia get?

Authors:  B Bandelow; K Sievert; M Röthemeyer; G Hajak; E Rüther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

Review 6.  Diagnosis and treatment of agoraphobia with panic disorder.

Authors:  Giulio Perugi; Franco Frare; Cristina Toni
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 7.  Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.

Authors:  Amber N Edinoff; Catherine A Nix; Amira S Odisho; Caroline P Babin; Alyssa G Derouen; Salim C Lutfallah; Elyse M Cornett; Kevin S Murnane; Adam M Kaye; Alan D Kaye
Journal:  Neurol Int       Date:  2022-08-22

8.  Clonazepam as agonist substitution treatment for benzodiazepine dependence: a case report.

Authors:  Angelo Giovanni Icro Maremmani; Luca Rovai; Fabio Rugani; Silvia Bacciardi; Matteo Pacini; Liliana Dell'osso; Icro Maremmani
Journal:  Case Rep Psychiatry       Date:  2013-01-30

9.  Three year naturalistic outcome study of panic disorder patients treated with paroxetine.

Authors:  Pinhas N Dannon; Iulian Iancu; Ami Cohen; Katherine Lowengrub; Leon Grunhaus; Moshe Kotler
Journal:  BMC Psychiatry       Date:  2004-06-11       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.